About Us

History

Founded in 2012 Skin Analytics is a research led company committed to helping more people to survive skin cancer.

Our team has developed a clinically validated machine learning tool, DERM AI, that has proven to be as sensitive and specific as a dermatologist. We have spent considerable time working with GP’s, dermatologists, NHS Trusts and leading researchers to ensure that DERM has a real clinical utility.

Meet The Team

Neil Daly

Neil Daly

CEO

Neil started Skin Analytics in 2012, having worked extensively in mobile innovation and strategy consulting for a number of years. He holds a BSc in Physics from the University of Western Australia and an Executive MBA from London Business School.
Helen Marsden

Helen Marsden

Clinical Research Director

Helen has 17 years of clinical research experience in both corporate and academic settings delivering clinical trials and data generation. She has authored seven peer-reviewed journals. Helen has a PhD in medical microbiology from Leeds University.
Jack Greenhalgh

Jack Greenhalgh

AI Director

Jack joined Skin Analytics having worked in computer vision and machine learning in both industry and academia for many years. He holds an MEng in Computer Systems Engineering from the University of Sussex and a Ph.D. in Computer Science from the University of Bristol.
David Puttergill

David Puttergill

Operations Director

David has 10 years of experience in Accounting, Finance and Operations in professional services, start-ups and most recently an FCA regulated lender. David is a Chartered Accountant (ICAEW) and has a BA in Geography from Oxford.

Jenny Dean

Jenny Dean

Medical (Digital) Director

Jenny has over 20 years experience in healthcare including 10 years as a doctor and 6 years as the Medical Director of Health IT companies. Her focus is on the clinical safety and usability of software solutions for clinician and patients. Jenny holds degrees in Medicine (MB ChB), an MSc in remote healthcare, and an MBA.

Rachael Dovey

Rachael Dovey

Business Development Manager

Rachael is an experienced commercial partnerships manager, who has worked with primary and secondary care organisations, to redesign service pathways in order to deliver better patient care that is sustainable for the NHS.

Jim Holmes

Jim Holmes

Technical Director

Jim has been working in technology for the last 20 years and is an experienced software engineer and technical architect.  He joined the Skin Analytics team after a 10 year position as CTO of a digital agency in London.  Jim has experience of building and scaling technology focused start-up businesses as well as previous experience in medical technology. Jim holds a BSc in Information Systems.

martin nwosu

martin nwosu

QA/RA Manager

Martin is an experienced quality assurance and regulatory professional  across a variety of high tech Industries. He specialises in establishing ISO compliant Quality Management Systems, achieving medical device CE marking and preparing global regulatory submissions. Martin holds a BSc in Aerospace Engineering and an MSc in Advanced Engineering Systems from Kingston University. 
Fin edridge

Fin edridge

Product Director

Fin shapes and drives the product roadmap for Skin Analytics, focusing on evolving our service to deliver ever better value and experience for our growing client base and the patients they serve.  His background is in technology innovation and systems delivery, with significant experience in the NHS including electronic prescriptions and electronic referral. Fin holds a BA (hons) and MEng from Cambridge University.
Yasmine Manshadi

Yasmine Manshadi

Operations Analyst

Yasmine has 4 years of industry and academic experience in a range of organisations in the medical, private and public sectors. Having worked in operations in both the UK and Australia, she joined the team at Skin Analytics to help drive and deliver the best outcomes for customers and partners. She holds a Bsc in Neuroscience from University College London.

Edozié Izegbu

Edozié Izegbu

Developer

Edozie has over 6 years of professional software development experience and over 3 years in entrepreneurship and startups. He is a Masters Candidate for Software Engineering at Oxford University and is writing his dissertation on Medical Software. 
Dan Mullarkey

Dan Mullarkey

Medical Director

Dan is a practicing GP who has experience working within the AI & Digital Health setting, working on the design, deployment and assessment of both direct-to-patient and clinician facing products. He sees the adoption of digital health technologies as a key step in helping healthcare services to evolve, offering support & efficiency improvements to clinicians and optimising patient experience. Dan holds degrees in Medicine (BMBS) and Biomedical Sciences (BMedSci) from the University of Nottingham.

Tim Daly

Tim Daly

HR Director

Tim has been involved with Skin Analytics since it started in 2012. He has a background in human resources, customer experience improvement and business development. Tim holds an MBA from the Australian Institute of Business.

Our Board

DOMINIC DODD

DOMINIC DODD

Chair, Non Executive Director, Advisor

Dominic was Managing Partner of Marakon Associates, a US-domiciled strategy consulting firm, where he worked for 15 years advising chief executives of plcs on growing long term value.

Since leaving Marakon he has worked as a chair, non executive director and advisor in the private, public and charity sectors, specialising in growth, turnaround and governance mainly in healthcare and financial services.

He is currently chair of two NHS trusts, the Royal Free London NHS Foundation Trust and the Royal National Orthopaedic Hospital NHS Trust. He is also a director of UCL Partners, the academic health science partnership and a trustee of health think tank The King’s Fund.

Juan Pane Arregui

Juan Pane Arregui

Entrepreneur and Business Angel

Juan spent 9 years working in software development at companies in Argentina and Spain and developed an anti virus in his free time. In 1995, he started Media Net Software and sold the company after 20 years while it was employing 200+ engineers in Spain, Mexico and the USA. From 1998 to 2004 Juan managed the digitizing projects for Diario El País and Diario El Mundo through a corporate venture we created ad-hoc, where they hired a team of 70+ professionals.

He is Current owner of Evoluciona, a digital interactive agency. He was the CEO from 2005 to 2013 and saw the company grow to work with blue chip companies such as Microsoft, BBVA, Acciona, RTVE, FOX or El Corte Inglés.

In 2005 he co-founded BuyVIP with two other partners. This e-commerce site grew to 100+ employees in five years and was operating in Germany, Italy, Spain, Portugal, Austria, Poland and The Netherlands. BuyVIP was sold to Amazon in 2010. In 2009 Juan co-founded Tech on Rails, an engineering services company specialized in high-speed trains and aeronautics.

Juan is an investor, advisor and/or board member at several companies and is always open to new opportunities where business strategy, processes or technology can be applied to move companies to the next stage.

michael buchen

michael buchen

Chairman of Polar Light Ventures Ltd and Investor

Michael is the Chairman and Founder of Polar Light Ventures Ltd., an investment firm based in Switzerland which is focusing on early stage ventures.

Previously he was the Managing Director of Dhabi Holdings PJSC, the investment company of senior members of the ruling family of Abu Dhabi. Michael Buchen joined Dhabi Holdings from Mubadala Development Company PJSC where he worked in the Special Situations Team. Before Mubadala, he worked for Roland Berger Strategy Consultants in Europe, China and the Middle East. Michael currently serves or previously served on the Board of directors and Advisory Boards of a number of companies in the Venture Capital, Tech, Financial Services, Food & Beverage, Energy and Telecom sector.

He holds a Master of Science in Business Management from the University of Muenster in Germany.

Get in Touch

  • This field is for validation purposes and should be left unchanged.